{"id":"NCT02181673","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of Golimumab in Participants With Active Psoriatic Arthritis","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFÎ± Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-08","primaryCompletion":"2016-05-05","completion":"2017-03-22","firstPosted":"2014-07-04","resultsPosted":"2017-12-21","lastUpdate":"2017-12-21"},"enrollment":480,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Psoriatic"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Golimumab","otherNames":[]}],"arms":[{"label":"Treatment Group 1: Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Treatment Group 2: Golimumab","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy of intravenously (administration of a fluid into the vein) administered golimumab 2 milligram per kilogram (mg/kg) in participants with active psoriatic arthritis (a chronic inflammatory arthritis that is associated with psoriasis).","primaryOutcome":{"measure":"Percentage of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response at Week 14","timeFrame":"Week 14","effectByArm":[{"arm":"Placebo","deltaMin":21.8,"sd":null},{"arm":"Golimumab","deltaMin":75.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":88,"countries":["United States","Australia","Belarus","Canada","Germany","Hungary","Lithuania","Poland","Romania","Russia","Spain","Ukraine"]},"refs":{"pmids":["35313978","32143685","30980514","30770519","28805045"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":239},"commonTop":["Alanine aminotransferase increased","Nasopharyngitis","Aspartate aminotransferase increased"]}}